IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 238 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $704,000 | -88.5% | 100,000 | -90.0% | 0.23% | -87.2% |
| Q1 2023 | $6,110,000 | -26.4% | 1,000,000 | -23.1% | 1.81% | -49.1% |
| Q4 2022 | $8,307,000 | -13.0% | 1,300,000 | +160.0% | 3.55% | +3.7% |
| Q4 2021 | $9,545,000 | -44.7% | 500,000 | -28.6% | 3.42% | -32.2% |
| Q3 2021 | $17,262,000 | +47.4% | 700,000 | +55.6% | 5.05% | +56.8% |
| Q2 2021 | $11,709,000 | -26.0% | 450,000 | -10.0% | 3.22% | -13.5% |
| Q1 2021 | $15,830,000 | -31.8% | 500,000 | 0.0% | 3.72% | -28.0% |
| Q4 2020 | $23,200,000 | +22.6% | 500,000 | -13.0% | 5.17% | -5.5% |
| Q3 2020 | $18,929,000 | +18.9% | 575,000 | -0.9% | 5.47% | +30.2% |
| Q2 2020 | $15,921,000 | +52.0% | 580,000 | +65.7% | 4.20% | +51.2% |
| Q1 2020 | $10,477,000 | -62.1% | 350,000 | -65.0% | 2.78% | -47.3% |
| Q4 2019 | $27,680,000 | +204.2% | 1,000,000 | +100.0% | 5.27% | +127.4% |
| Q3 2019 | $9,100,000 | +147.4% | 500,000 | +233.3% | 2.32% | +203.8% |
| Q2 2019 | $3,678,000 | -66.4% | 150,000 | -87.0% | 0.76% | -73.3% |
| Q1 2019 | $10,937,000 | +23.6% | 1,150,000 | +15.0% | 2.86% | -11.1% |
| Q4 2018 | $8,850,000 | +92.1% | 1,000,000 | +177.8% | 3.21% | +136.9% |
| Q2 2018 | $4,608,000 | -72.7% | 360,000 | -64.0% | 1.36% | -60.3% |
| Q1 2018 | $16,900,000 | +318.0% | 1,000,000 | +81.8% | 3.42% | +307.0% |
| Q2 2017 | $4,043,000 | – | 550,000 | – | 0.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 11,826,299 | $130,562,000 | 4.09% |
| MPM BioImpact LLC | 1,200,000 | $13,248,000 | 3.68% |
| Finepoint Capital LP | 960,200 | $10,601,000 | 3.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,011 | $273,000,000 | 2.85% |
| Avoro Capital Advisors LLC | 9,220,000 | $101,789,000 | 2.01% |
| Long Focus Capital Management, LLC | 1,625,000 | $17,940,000 | 1.88% |
| 683 Capital Management, LLC | 2,000,000 | $22,080,000 | 1.56% |
| Parametrica Management Ltd | 115,870 | $1,268,000 | 1.38% |
| Boxer Capital, LLC | 1,935,133 | $21,364,000 | 1.35% |
| Soleus Capital Management, L.P. | 719,600 | $7,944,000 | 1.24% |